StockUS listing USFUJIFPINKIndustrialsBalanced

FUJIFILM Holdings Corporation(FUJIF) Stock Analysis | Industrials

USD --+0.00%
Reward50Moderate
Risk32Moderate
75%Data
2.4% dividend yield
USD —+0.00 (+0.00%) Previous close · PINK
Market cap 26.89Bn
Reward Ratingⓘ50 Moderate reward assessment · 75% data coverage
Bottom 50% of stocksView factors
Risk Ratingⓘ32 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on FUJIF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is FUJIFILM Holdings Corporation?

FUJIFILM Holdings Corporation provides products and services in the fields of healthcare, electronics, business innovation, and imaging in Japan, the Americas, Europe, Asia, and internationally.

AI Brief Pro

The brief on FUJIFILM Holdings Corporation

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is FUJIFILM Holdings Corporation?

FUJIFILM Holdings Corporation provides products and services in the fields of healthcare, electronics, business innovation, and imaging in Japan, the Americas, Europe, Asia, and internationally. The Healthcare segment offers products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment; equipment and materials for medical systems; drug discovery support, such as iPS cells; and cell culture media and reagents. The company is listed on the PINK in USA, operating in the Industrials sector, with a market capitalisation of 26.89B, and a P/E ratio of 13.9x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (50)
Company Information
SectorIndustrials
IndustryConglomerates
P/E Ratio13.9384
Beta0.351
Insider Activity
12M windowNo data
No insider activity data available for this ticker.